Infection-related hospitalization and risk of end-stage renal disease in patients with systemic lupus erythematosus: a nationwide population-based study

Nephrol Dial Transplant. 2017 Oct 1;32(10):1683-1690. doi: 10.1093/ndt/gfw407.

Abstract

Background: Infections are a major cause of morbidity in patients with systemic lupus erythematosus (SLE), and may lead to death. No nationally representative study of patients with SLE has examined the rates of infection-related hospitalization and the risk of end-stage renal disease (ESRD).

Methods: We conducted a nationwide cohort study of 7326 patients with newly diagnosed SLE and no history of ESRD. All data were from Taiwan's National Health Insurance claims database for the period 2000-11.

Results: Among all SLE patients, 316 (4.3%) developed ESRD (mean follow-up time: 8.1 years). Multivariate Cox regression analysis indicated that the risk of ESRD increased with the number of infection-related hospitalizations. For patients with three or more infection-related admissions, the hazard ratio (HR) for ESRD was 5.08 [95% confidence interval (CI): 3.74-6.90] relative to those with no infection-related admission. Analysis by type of infection indicated that bacteremia patients had the greatest risk for ESRD (HR: 4.82; 95% CI: 3.40-6.85). Analysis of age of SLE onset indicated that patients with juvenile-onset (<18 years) and three or more infection-related hospitalizations had a greatly increased risk for ESRD (HR: 14.49; 95% CI: 5.34-39.33).

Conclusions: Infection-related hospitalizations are associated with a significantly increased risk of ESRD in patients with SLE, especially those with juvenile-onset SLE. Among patients with different types of infectious diseases, those with bacteremia were more likely to develop ESRD.

Keywords: National Health Insurance; end-stage renal disease; hospitalization; infection; systemic lupus erythematosus.

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Bacterial Infections / etiology*
  • Bacterial Infections / mortality
  • Bacterial Infections / therapy
  • Cohort Studies
  • Female
  • Hospitalization
  • Humans
  • Incidence
  • Kidney Failure, Chronic / etiology*
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / therapy
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / mortality
  • Lupus Erythematosus, Systemic / therapy
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Proportional Hazards Models
  • Risk Factors
  • Young Adult